Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study)

Figure 2

Proportion of patients achieving the glycemic target (HbA1c ≤ 7.0%) at 24 weeks. Free DC: free drug combination; Vilda/Met FDC: vildagliptin + metformin fixed dose combination.